View the PDF of this article at: https://www.the-jci.org/press/17166.pdf
Peptide-based treatment for autoimmune diseases: learning how to handle a double-edged sword
Diabetes Research Institution, University of Miami, Miami, Florida, USA
Phone : 305-243-5348
Fax : 305-243-4404
View the PDF of this commentary at: https://www.the-jci.org/press/18395.pdf
Activation of the m opioid receptor provides calm for the colon
Excessive inflammation in the intestine is characteristic of inflammatory bowel disease (IBD). Researchers now show that administration beneath the skin of compounds that selectively inhibit the m opioid receptor in the colon are capable of preventing colitis in mice. These results suggest that such compounds may have therapeutic potential in IBD patients.
Hopital Huriez, Service de Gastro-enterologie, Lille, France.
View the PDF of this article at: https://www.the-jci.org/press/16750.pdf
Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension
University of Vienna, Vienna, Austria.
Contact: Brooke Grindlinger
Journal of Clinical Investigation